Enterprise Value
2.103M
Cash
617.4K
Avg Qtr Burn
-2.878M
Short % of Float
5.16%
Insider Ownership
0.89%
Institutional Own.
0.18%
Qtr Updated
12/31/23
Drug Pipeline
Powered by
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
Bentrio® nasal spray / AM-301 Details Seasonal allergic rhinitis | Approved Quarterly sales |